Boston Scientific BSX
NYSE BSX
$45.06 +0.67 (+1.50%)
At close: Oct 19, 2026 · 4:00 PM EDT

Boston Scientific (BSX) Gains from Sales and Divestitures (2011 - 2022)

Updated

Boston Scientific (BSX) recorded Gains from Sales and Divestitures of -$22 million in Q4 2022, compared with $30 million a year earlier.

Analysis

Boston Scientific (BSX) Gains from Sales and Divestitures (2011 - 2022) Analysis & Trends

Starting with Q1 2011, Boston Scientific's Gains from Sales and Divestitures history includes 6 quarters.

  • Across earlier years, Gains from Sales and Divestitures came in at $78 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn
10 Agilent Technologies 47.87 Bn 40.76 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -22.00 Mn
Dec 31, 2021 30.00 Mn
Sep 30, 2021 39.00 Mn
Jun 30, 2021 3.00 Mn
Mar 31, 2021 6.00 Mn
Mar 31, 2011 778.00 Mn
API Access

Boston Scientific Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BSX&period=max&api_key=YOUR_API_KEY